1 / 25

Case Presentation #14

Case Presentation #14 Jim Pointer, MD Alameda County EMS Medical Director Complaint You are called to a night-club at 0200. The “bouncer” tells you that a young male patient is in the “back room”, unconscious. Initial Assessment An unconscious, twenty-ish white male Airway: intact

paul
Télécharger la présentation

Case Presentation #14

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Case Presentation #14 Jim Pointer, MD Alameda County EMS Medical Director

  2. Complaint • You are called to a night-club at 0200. The “bouncer” tells you that a young male patient is in the “back room”, unconscious.

  3. Initial Assessment • An unconscious, twenty-ish white male • Airway: intact • Respirations: 8 per minute • Good radial pulses • Glascow Coma Scale: 5

  4. Focused History and Physical Exam • Patient had “3 beers” according to his girlfriend • He rapidly became somnolent, then unconscious, after dropping “something” in his drink

  5. Pertinent Findings • B/P: 136/80 • RR: 10 • PR: 54 • Pulse Ox: 99% (room air) • Pupils: non-reactive (4mm) • Neuro: GCS: 4 (occ. myoclonic movements) • EKG: occasional U waves present

  6. 12-lead EKG

  7. Past Medical History • Non-contributory • Patient training to be a “stockbroker”

  8. Initial Treatment • Non-rebrather mask 100% O2 • IV Normal Saline • Dextrostix: 90 mg/dl • Naloxone 0.5mg IV  No response • Transport

  9. Hospital Findings • Unconscious young male in NAD • Vital signs: B/P – 134/78, PR – 52, RR – 9, Temp – 96.8 (rectally), Pulse Ox – 100% • Neuro: • pupils 3-4 mm, non-reactive and equal • Absent deep tendon reflexes • Myotonic jerks • Minimal response to painful stimuli

  10. Lab Studies • CBC: WBC – 10.2K, H & H – 16.2/49.3 • Chemistries: BUN, creatinine, electrolytes, LFTs, glucose – WNL • Tox Screen: negative for drugs of abuse • Blood Alcohol: 0.09

  11. CT Scan Negative

  12. Brief Differential Diagnosis • Intracranial pathology • Toxic ingestion • CNS infection • Metabolic disorder

  13. Gamma Hydroxybutyrate (GHB) • Emergency drug of abuse • Promoted for “health” benefits • Range of toxic effects • Steep dose-response curve • Party and “date rape” drug

  14. Chemical Structure of GHB -Hydroxybutyric Glutamic -Aminobutyric Acid Acid Acid

  15. GHC - Background • GHB and precursors, GBL and I,4BD are frequently abused • First developed as anesthetics in 1960 • Cuurently used in narcolepsy trials • Became popular in 1980’s • Party drug at “raves” • Dietary supplements and growth hormone stimulators

  16. Background – Cont. • 4969 ED visits in 2000 (55 in 1994) • FDA: “illicet, unapproved drug” (schedule I) • Readily available on the internet

  17. Dosage • Rapidily crosses blood-brain barrier • 10 mg/kg: anxiolytic effects • 20-30 mg/kg: somnolence to euphoria • 30 mg/kg: sleep, hallucinations, myoclonia • 50 mg/kg: anesthesia • > 50 mg/kg: coma

  18. Usage • 55%: Bodybuilders • 41%: Weight loss • 27%: Sleep • 5%: Euphoria

  19. Self-Reported Symptoms • 73%: Drowsiness • 46%: Feeling “high” • 41%: Dizziness • 32%: Increased arousal • 9%: Loss of peripheral vision

  20. Clinical Syndrome • Rapidly decreasing LOC • Relatively intact B/P and respirations • Minimal absent DTRs • Non-reactive pupils of variable size • Bradycardia • Mild reversible hypothermia • Vomiting within one hour of ingestion • Incontinence • Agitation/combativeness

  21. Initial GCS Scores86 GHB patients at SFGH Glascow Coma Scale

  22. Serious Toxicity • Trauma – head-banging • Aspiration pneumonia • Seizures • Asphyxiation • Respiratory depression – pulmonary edema • Co-intoxicants

  23. Pharmacokinetics • Time to peak: 25-45 minutes • Hepatic metabolism • Levels decrease rapidly over several hours • 8 hours serum • 12 hours urine • Urine may be preferred testing medium • Steep dosage response curve • LOC dose (50-60 mg/kg) less than 2 times the recreational dose (35 mg/kg)  75-100 mg/kg dose 

  24. Populations at Risk • Recreational users – raves etc. • Users for “health benefits” – bodybuilders, weight loss, insomnia, anxiety, depression • Addicts • Intoxicated drivers • Victims of surreptitious drugging • Victims of accidental ingestions

  25. References • Chin RL, Sporer KA, Cullison B, et al. Clinical Course of gamma-hydroxybutyrate overdose. Annals of Emergency Medicine 1998; 31: 716-722 • O’Connell T, Kaye L, Plusay JJ. Gamma-hydroxybutyrate: a newer drug of abuse. American Family Physician 2000; 62: 2478-83

More Related